About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

The Study of Atypical Antipsychotics-induced Metabolic Disturbances

NCT00937755·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Taipei Medical University Hospital

With

National Science and Technology Council, Taiwan
Department of Health, Executive Yuan, R.O.C. (Taiwan)

Age

18–60

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

clinical diagnosis of schizophrenia
age 18-60 years

You may not be if

received any SGAs prior to this study
medical conditions that may confound glucoregulatory assessment
pregnancy

The record

StatusCompleted

PhaseNo phase

Taking part80

StartedMar 2006

UpdatedJul 13, 2009

Conditions

Schizophrenia Antipsychotics

Where1

Taipei Medical University-Municipal Wan-Fang Hospital
Taipei, Taiwan

Clareo Health | The Study of Atypical Antipsychotics-induced Metabolic Disturbances